Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term health economics of Duodopa in advanced Parkinson's disease
2005-002654-21Phase 4Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levodopa in Parkinson's disease (PD), sponsored by Solvay Pharmaceuticals. Primary endpoint: Resource use for cost evaluation. Started Jun 2005; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-002654-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002654-21.